Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Transulnar Access: Another Ace Up Our Sleeve Before Transfemoral Access

Transulnar access can be as safe and effective as transradial access, and it is a particularly good alternative for the preservation of radial artery patency or when such vessel presents a difficult anatomy. This new meta-analysis that will be published soon in Catheter Cardiovasc Interv showed a relatively high failure rate for that access, but that could be easily explained by a learning curve.

El acceso cubital puede ser un as en la manga extra antes de pensar en el femoralIn terms of safety, neither excess bleeding/bruising nor other vascular complications were observed with transulnar access when compared with transradial access in patients who underwent angioplasty. However, the rate of failure for transulnar access more than doubled that for transradial access (odds ratio [OR]: 2.63).

 

This meta-analysis included 6 trials with about 4800 patients and showed that transulnar access was not associated with increased fluoroscopy time, contrast volume or access time.


Read also: Tips to Prevent Radial Occlusion after Catheterization.


Transulnar access can be considered an alternative in cases in which operators need to preserve the radial artery for bypass grafts or arteriovenous fistulae for patients with poor kidney function. Additionally, the ulnar artery tends to offer higher bore and lower tortuosity than the radial artery.

 

On the other hand, the transulnar artery is deeper and getting a pulse is often more difficult. If we only remember it when we run into problems with transradial access, we probably will not get the necessary experience in using this access site.

 

The ideal course of action seems to be the assessment of access on a case-by-case basis, depending on the relative size of the radial and ulnar arteries.


Read also: Transradial Access and Early Discharge in Percutaneous Interventions.


A common concern regarding this access is that the ulnar nerve lies right next to the artery through the Guyon canal, between the pisiform bone and the ulnar artery. Since, generally, the patient is positioned with his/her arm right next to his/her body, the puncture will always be more likely to fall on the free side of the artery (which is ideal) and not near the nerve. Pseudoaneurysms should also be taken into account, since the ulnar artery is deeper and there are no bony structures for good compression. In conclusion, until we gain sufficient experience, post-procedural monitoring should be closer than current monitoring of patients with transradial access.

 

Original title: Safety and Efficacy of Ulnar Artery Approach for Percutaneous Cardiac Catheterization: Systematic Review and Meta-Analysis.

Reference: Fernandez R et al. Catheter Cardiovasc Interv. 2018; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | P2Y12 Inhibitor Monotherapy After Complex PCI in ACS: Results From the NEO-MINDSET COMPLEX Subanalysis

This is a summary of the NEO-MINDSET COMPLEX subanalysis, presented by Dr. Guy Prado at EuroPCR 2026, which evaluated P2Y12 inhibitor monotherapy versus dual...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

EuroPCR 2026 | Could clopidogrel replace aspirin as monotherapy after PCI?

This presentation, delivered during EuroPCR 2026, analyzed the clinical outcomes of clopidogrel monotherapy versus aspirin in patients who remained event-free for 12 months after...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...